Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Pulmonary Circulation|November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 14, 2012
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung TransplantationJames C Fang, Teresa DeMarco, Michael M Givertz, et al.
American Heart Journal|May 3, 2005
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failureRobert P Frantz, Lyle J Olson, Diane Grill, et al.
Chest|May 26, 2012
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trialVictor F Tapson, Fernando Torres, Fiona Kermeen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2003
Clinical predictors of exercise capacity 1 year after cardiac transplantationTat-Chi Leung, Karla V Ballman, Thomas G Allison, et al.
Transplantation Proceedings|June 23, 2011
Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathyE Raichlin, S S Kushwaha, R C Daly, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2021
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel AdvancesBradley A Maron, Steven H Abman, C Greg Elliott, et al.
Respiratory Medicine|December 5, 2022
Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association RegistryAnne B Rohlfing, Kara E Bischoff, Nicholas A Kolaitis, et al.
Chest|December 15, 2010
Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertensionArun Sachdev, Hector R Villarraga, Robert P Frantz, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Pulmonary Circulation|November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 14, 2012
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung TransplantationJames C Fang, Teresa DeMarco, Michael M Givertz, et al.
American Heart Journal|May 3, 2005
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failureRobert P Frantz, Lyle J Olson, Diane Grill, et al.
Chest|May 26, 2012
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trialVictor F Tapson, Fernando Torres, Fiona Kermeen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2003
Clinical predictors of exercise capacity 1 year after cardiac transplantationTat-Chi Leung, Karla V Ballman, Thomas G Allison, et al.
Transplantation Proceedings|June 23, 2011
Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathyE Raichlin, S S Kushwaha, R C Daly, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2021
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel AdvancesBradley A Maron, Steven H Abman, C Greg Elliott, et al.
Respiratory Medicine|December 5, 2022
Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association RegistryAnne B Rohlfing, Kara E Bischoff, Nicholas A Kolaitis, et al.
Chest|December 15, 2010
Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertensionArun Sachdev, Hector R Villarraga, Robert P Frantz, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Pageof 25